Global Human Milk Oligosaccharides (HMO) Market

Global Human Milk Oligosaccharides (HMO) Market Size, Share, Growth Analysis, By Type(2'-FL & 3-FL, Sialyllactose), By Application(Segmented as, Infant Formula) - Industry Forecast 2024-2031


Report ID: SQMIG30I2309 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 65 | Figures: 75

Global Human Milk Oligosaccharides (HMO) Market Regional Insights

The human milk oligosaccharides (HMO) market showed notable regional variations, with North America having the largest market share. North America's advanced baby feeding business, robust research capacity, and increasing consumer demand for HMO-fortified goods are the reasons for its dominance. The notable use of HMOs in infant formula and related products can be attributed to the region's focus on ensuring optimal infant health and development.

Europe is now the second-biggest market for HMOs, after North America. Similar emphasis on infant health and nourishment, along with a pro-active regulatory structure that encourages the entry of new ingredients into the food and beverage industry, are advantageous for the European market. The use of HMOs in baby formula and other applications has been further supported by European consumers' preference for useful and health-improving products.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Human Milk Oligosaccharides (HMO) Market size was valued at USD 177.91 Million in 2022 and is poised to grow from USD 195.17 Million in 2023 to USD 409.32 Million by 2031, at a CAGR of 9.7% during the forecast period (2024-2031). 

The human milk oligosaccharides (HMO) market is very competitive, with both well-established manufacturers and creative entrants vying for market share as demand for HMO-fortified products rises. Prominent competitors include DuPont Nutrition & Biosciences, Nestlé S.A., Glycosyn LLC, Jennewein Biotechnologie GmbH, and Elicityl owing to their experience producing HMOs, their capacity for extensive research, and their established relationships in the infant nutrition and functional foods industries. 'DuPont Nutrition & Biosciences', 'Nestlé S.A.', 'Glycosyn LLC', 'Jennewein Biotechnologie GmbH', 'Elicityl', 'Inbiose', 'ZuChem Inc.', 'Glycom A/S', 'TMO Renewables Ltd.', 'Abbott Laboratories', 'Evolve Biosystems', 'Quantum Biotechnologies Inc.', 'Novalac', 'ZuChem Inc.', 'Clasado Biosciences', 'Metabiotics Corporation', 'Medolac Laboratories', 'HMO Research GmbH', 'Jennewein Biotechnologie', 'Holton BioSystems'

The growing awareness of the advantages of human milk oligosaccharides (HMOs) for health is an important driver . Demand for HMO-fortified goods has increased as a result of the role that HMOs play in promoting the immune system, cognitive development, and gut health of infants as well as possible benefits for adults.

Expanding Applications Beyond Infant Nutrition: Although HMOs have historically been linked to baby feeding and are found naturally in breast milk, there is a rising movement to investigate their potential in other contexts. HMOs are being researched for use in functional foods, dietary supplements, and even medications to treat a range of health issues in people of different ages.

The human milk oligosaccharides (HMO) market showed notable regional variations, with North America having the largest market share. North America's advanced baby feeding business, robust research capacity, and increasing consumer demand for HMO-fortified goods are the reasons for its dominance. The notable use of HMOs in infant formula and related products can be attributed to the region's focus on ensuring optimal infant health and development.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Human Milk Oligosaccharides (HMO) Market

Product ID: SQMIG30I2309

$5,300
BUY NOW GET FREE SAMPLE